Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes.
Wu Y, Qi Z, Wang B, Wang J, Liu Q, Wang A, Shi C, Zhou B, Liang Q, Wang W, Zou F, Qi S, Wang Z, Wang L, Wang W, Liu J, Liu Q.
Wu Y, et al. Among authors: wang w, wang l, wang j, wang z, wang b, wang a.
J Med Chem. 2022 Sep 8;65(17):11818-11839. doi: 10.1021/acs.jmedchem.2c00926. Epub 2022 Aug 29.
J Med Chem. 2022.
PMID: 36037148